In vivo imaging of early stage apoptosis by measuring real-time caspase-3/7 activation

Apoptosis

Volumn 16, Issue 2, 2011, Pages 198-207

  Scabini, Matteo ^a   Stellari, Fabio ^a   Cappella, Paolo ^b   Rizzitano, Sara ^a   Texido, Gemma ^a   Pesenti, Enrico ^a  

^a Pharmacology Department   (Italy)

^b Biology Department   (Italy)

Author keywords

Apoptosis; Bioluminescence imaging; Caspase 3; Xenogen; Z DEVD aminoluciferin

Indexed keywords

CAMPTOTHECIN; CASPASE 3; CASPASE 7; LUCIFERASE; LUCIFERIN; TEMOZOLOMIDE; TUMOR MARKER; UNCLASSIFIED DRUG; VIVOGLO;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BIOLUMINESCENCE; CANCER INHIBITION; COLON CANCER; CONTROLLED STUDY; ENZYME ACTIVATION; GLIOBLASTOMA; HUMAN; HUMAN CELL; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; TUMOR CELL; TUMOR VOLUME; XENOGRAFT;

ANIMALS; APOPTOSIS; BLOTTING, WESTERN; CAMPTOTHECIN; CASPASE 3; CASPASE 7; CELL LINE, TUMOR; CELL PROLIFERATION; COLONIC NEOPLASMS; DACARBAZINE; ENZYME ACTIVATION; FIREFLY LUCIFERIN; FLOW CYTOMETRY; GLIOBLASTOMA; HUMANS; LUMINESCENT MEASUREMENTS; LUMINESCENT PROTEINS; MICE; MICE, NUDE; OLIGOPEPTIDES; STAINING AND LABELING; XENOGRAFT MODEL ANTITUMOR ASSAYS;

ANIMALIA; MUS;

EID: 79951575617     PISSN: 13608185     EISSN: 1573675X     Source Type: Journal    
DOI: 10.1007/s10495-010-0553-1     Document Type: Article

References (31)

1. MO Hengartner 2000 The biochemistry of apoptosis Nature 407 770 776 1:CAS:528:DC%2BD3cXnsFWrsLc%3D 10.1038/35037710 11048727
2. S Fulda 2003 Tumor resistance to apoptosis Int J Cancer 124 511 515 10.1002/ijc.24064
3. 6- methylguanine Oncogene 26 186 197 1:CAS:528:DC%2BD2sXjsFOlsQ%3D%3D 10.1038/sj.onc.1209785 16819506 (Pubitemid 46095730)
4. Y Xu MA Villalona-Calero 2002 Irinotecan: mechanisms of tumor resistance and novel strategies for modulating its activity Ann Oncol 13 1841 1851 1:STN:280:DC%2BD38nptF2nsQ%3D%3D 10.1093/annonc/mdf337 12453851 (Pubitemid 36040772)
5. Z Jin WS El Deiry 2005 Overview of cell death signaling pathway Cancer Biol Ther 4 139 163 1:CAS:528:DC%2BD28XhvFKgs7k%3D 10.4161/cbt.4.2.1508 15725726 (Pubitemid 41351311)
6. FL Kiechle X Zhang 2002 Apoptosis: biochemical aspects and clinical implications Clin Chim Acta 326 27 45 1:CAS:528:DC%2BD38XosFertrw%3D 10.1016/S0009-8981(02)00297-8 12417095 (Pubitemid 35341162)
7. J Rotonda DW Nicholson KM Fazil, et al. 1996 The three-dimensional structure of apopain/CPP32, a key mediator of apoptosis Nat Struct Biol 3 619 625 1:CAS:528:DyaK28XktVahur4%3D 10.1038/nsb0796-619 8673606 (Pubitemid 26239210)
8. MG Grutter 2000 Caspases: key players in programmed cell death Curr Opin Struct Biol 10 649 655 1:CAS:528:DC%2BD3MXms1Sjtg%3D%3D 10.1016/S0959-440X(00) 00146-9 11114501 (Pubitemid 32061479)
9. BW Lee MR Olin GL Johnson RJ Griffin 2008 In vitro and in vivo apoptosis detection using membrane permeant fluorescent-labeled inhibitors of caspases Methods Mol Biol 414 109 135 1:CAS:528:DC%2BD2sXhtlerurnI 10.1007/978-1-59745- 339-4-10 18175816
10. K Kuzelová D Grebenová Z Hrkal 2007 Labeling of apoptotic JURL-MK1 cells by fluorescent caspase-3 inhibitor FAM-DEVD-fmk occurs mainly at site(s) different from caspase-3 active site Cytometry A 71 605 611 17549763 (Pubitemid 47221723)
11. EM Barnett X Zhang D Maxwell, et al. 2009 Single-cell imaging of retinal ganglion cell apoptosis with a cell-penetrating, activatable peptide probe in an in vivo glaucoma model PNAS 106 9391 9396 1:CAS:528:DC%2BD1MXot1Cgurs%3D 10.1073/pnas.0812884106 19458250
12. P Ray A De M Patel SS Gambhir 2008 Monitoring caspase-3 activation with a multimodality imaging sensor in living subjects Clin Cancer Res 14 5801 5809 1:CAS:528:DC%2BD1cXhtFaitrvJ 10.1158/1078-0432.CCR-07-5244 18794090
13. T Troy D Jekic-McMullen, et al. 2004 Quantitative comparison of the sensitivity of detection of fluorescent and bioluminescent reporters in animal models Mol Imaging 3 9 29 1:CAS:528:DC%2BD2cXkslGjsLs%3D 10.1162/ 153535004773861688 15142408
14. VV Tuchin RK Wang AT Yeh 2008 Optical clearing of tissues and cells J Biomed Opt 13 021101 10.1117/1.2903745 18465950
15. Yang Y, Hong H, Zhang Y, Cai W (2009) Molecular imaging of proteases in cancer. Pubmed Central. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2838618/. Accessed in PMC 2010 March 15
16. B Laxman DE Hall MS Bhojani, et al. 2002 Noninvasive real-time imaging of apoptosis PNAS 99 16551 16555 1:CAS:528:DC%2BD3sXhvVyrtw%3D%3D 10.1073/pnas.252644499 12475931 (Pubitemid 36034010)
17. JJ Liu W Wang DT Dicker, et al. 2005 Bioluminescent imaging of TRAIL-induced apoptosis through detection of caspase activation following cleavage of Z-DEVD-aminoluciferin Cancer Biol Ther 4 885 892 1:CAS:528:DC%2BD28XkvVSnsbc%3D 16177559
18. S Kizaka-Kondoh S Itasaka, et al. 2009 Selective killing of hypoxia-inducible factor-1-active cells improves survival in a mouse model of invasive and metastatic pancreatic cancer Clin Cancer Res 15 3433 3441 1:CAS:528:DC%2BD1MXmtVKmu7Y%3D 10.1158/1078-0432.CCR-08-2267 19417024
19. J Hickson S Ackler D Klaubert, et al. 2010 Noninvasive molecular imaging of apoptosis in vivo using a modified firefly luciferase substrate, Z-DEVD-aminoluciferin Cell Death Differ 17 1003 1010 1:CAS:528: DC%2BC3cXlslyhurY%3D 10.1038/cdd.2009.205 20057500
20. L Zeng S Kizaka-Kondoh S Itasaka, et al. 2007 Hypoxia inducible factor-1 influences sensitivity to paclitaxel of human lung cancer cell lines under normoxic conditions Cancer Sci 98 1394 1401 1:CAS:528:DC%2BD2sXhtVaksrrE 10.1111/j.1349-7006.2007.00537.x 17608771 (Pubitemid 47241762)
21. F Del Bene M Germani G De Nicolao, et al. 2009 A model-based approach to the in vitro evaluation of anticancer activity Cancer Chemother Pharmacol 63 827 836 1:CAS:528:DC%2BD1MXitlWhsb0%3D 10.1007/s00280-008-0798-3 18663447
22. HS Friedman T Kerby H Calvert 2000 Temozolomide and treatment of malignant glioma Clin Cancer Res 6 2585 2597 1:CAS:528:DC%2BD3cXlslentrw%3D 10914698 (Pubitemid 30482092)
23. JS Nair E de Stanchina GK Schwartz 2009 The topoisomerase I poison CPT-11 enhances the effect of the Aurora B kinase inhibitor AZD1152 both in vitro and in vivo Clin Cancer Res 15 2022 2030 1:CAS:528:DC%2BD1MXjtF2rt70%3D 10.1158/1078-0432.CCR-08-1826 19276280
24. K Shah CH Tung XO Breakefield, et al. 2005 In vivo imaging of S-TRAIL-mediated tumor regression and apoptosis Mol Ther 11 926 931 1:CAS:528:DC%2BD2MXks1ajsbs%3D 10.1016/j.ymthe.2005.01.017 15922963 (Pubitemid 40724111)
25. D Lindner D Raghavan 2009 Intra-tumoural extra-cellular pH: a useful parameter of response to chemotherapy in syngeneic tumour lines Br J Cancer 100 1287 1291 1:CAS:528:DC%2BD1MXksF2gsrc%3D 10.1038/sj.bjc.6605022
26. M Tiefenthaler A Amberger N Bacher, et al. 2001 Increased lactate production follows loss of mitochondrial membrane potential during apoptosis of human leukaemia cells Br J Haematol 114 574 580 1:CAS:528:DC%2BD3MXntlansLc%3D 10.1046/j.1365-2141.2001.02988.x 11552982 (Pubitemid 32953635)
27. Tisi L et al. (2010). PH tolerant luciferase. US Patent 68,739. Washington, DC. US Patent and Trademark Office http://ip.com/patapp/ US20100068739. 18 May 2010
28. PG Ekert J Silke DL Vaux 1999 Caspase inhibitors Cell Death Differ 6 1081 1086 1:CAS:528:DC%2BD3cXivVequw%3D%3D 10.1038/sj.cdd.4400594 10578177
29. Z Darzynkiewicz E Bedner P Smolewski, et al. 2002 Detection of caspases activation in situ by fluorochrome-labeled inhibitors of caspases (FLICA) Meth Molec Biol 203 289 299 1:CAS:528:DC%2BD38XksVWju7w%3D
30. DS Tan GV Thomas MD Garrett, et al. 2009 Biomarker-driven early clinical trials in oncology: a paradigm shift in drug development Cancer J 15 406 420 1:CAS:528:DC%2BD1MXhtlyqsLbK 10.1097/PPO.0b013e3181bd0445 19826361
31. O Hurko 2009 The uses of biomarkers in drug development Ann N Y Acad Sci 1180 1 10 1:CAS:528:DC%2BD1MXhsFWltL3F 10.1111/j.1749-6632.2009.04946.x 19906255